BNP Paribas Asset Management
COLL icon

BNP Paribas Asset Management’s Collegium Pharmaceutical COLL Stock Holding History

BNP Paribas Asset Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.7K Buy
656
+44
+7% +$1.5K ﹤0.01% 2001
2026
Q1 		$20.2K Sell
612
-8,354
-93% -$354K ﹤0.01% 2028
2025
Q4 		$415K Buy
8,966
+8,626
+2,537% +$361K ﹤0.01% 1271
2025
Q3 		$12K Hold
340
– – ﹤0.01% 1566
2025
Q2 		$10K Buy
+340
New +$9.7K ﹤0.01% 1765

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

BNP Paribas Asset Management's COLL Position: Q2 2026 in Review

BNP Paribas Asset Management increased its Collegium Pharmaceutical (COLL) stake by 7.2% in Q2 2026, buying an estimated $1.5K and bringing the position to 656 shares worth $23.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2001.

BNP Paribas Asset Management first reported a position in COLL in Q2 2025 and has held it in 5 quarters since. The position peaked at $415K in Q4 2025. 257 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • BNP Paribas Asset Management held 656 shares of Collegium Pharmaceutical worth $23.7K as of Q2 2026.
  • BNP Paribas Asset Management bought 44 Collegium Pharmaceutical shares in Q2 2026, an estimated $1.5K.
  • Collegium Pharmaceutical made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q2 2026, its #2001 holding.
  • BNP Paribas Asset Management first reported a position in Collegium Pharmaceutical in Q2 2025 and has held it in 5 quarters since.
  • BNP Paribas Asset Management's Collegium Pharmaceutical position peaked at $415K in Q4 2025.
  • 257 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.